Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)

CUSIP: 71722W107

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
-469,204
Put/Call ratio
5.4%
SEC-reported price per share
$16.59
Number of holders
173
Value change
-$3,898,620
Number of buys
95
Open additional details 1 more signal available
Number of sells
60
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
79,611,764

Security key

71722W107

Report period

Q4 2025

Institutions

173

Top holders

10

Ownership snapshot

Top reported holders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Frazier Life Sciences Pub...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
15/15
Latest evidence
01 Nov 2025
13D/G 13F 3/4/5 Lead comparable stake: 8.6% 13D/G row: Frazier Life Sciences Public Fund, L.P. Showing 1-6 of 15 holder rows.

Quick read

Frazier Life Sciences Public Fund, L.P. leads the comparable SEC ownership view at 8.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Frazier Life Sciences Public Fund, L.P.'s linked filing trail.
Comparable ownership Top 5
Frazier Life Sciences Public Fund... 8.6%
Carlyle Group Inc. 4.9%
PRUDENTIAL FINANCIAL INC 0%
Frazier Life Sciences Management,... 16%
Medicxi Ventures Management (Jers... 9.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Frazier Life Sciences Public Fund, L.P.
13D/G
James N. Topper
8.6%
$70,447,299
5,985,327 shares
$0 01 Nov 2025
Carlyle Group Inc.
13F 13D/G
Company
4.9%
from 13D/G
$41,052,526
3,496,808 shares
30 Sep 2025
PRUDENTIAL FINANCIAL INC
13D/G
0%
$8,705
2,630 shares
-$24,547,397 31 May 2025
Frazier Life Sciences Management, L.P.
13F
Company
13F
16%
$146,730,576
12,466,489 shares
30 Sep 2025
Medicxi Ventures Management (Jersey) Ltd
13F 3/4/5
Company · 10%+ Owner
9.4%
$87,858,012
7,464,572 shares
30 Sep 2025
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
6.4%
$59,808,678
5,081,451 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
173
Shares
61,960,214
Rows available
173
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
132
Q4 2025 holders
173
Holder diff
41
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .